{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:11:00Z","timestamp":1792512660544,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China (NSFC)","doi-asserted-by":"crossref","award":["81170418"],"award-info":[{"award-number":["81170418"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20131084"],"award-info":[{"award-number":["BK20131084"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.intimp.2016.06.008","type":"journal-article","created":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T12:03:13Z","timestamp":1466251393000},"page":"238-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Puerarin protects against CCl4-induced liver fibrosis in mice: possible role of PARP-1 inhibition"],"prefix":"10.1016","volume":"38","author":[{"given":"Shuai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu-Cheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Tao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2016.06.008_bb0005","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2016.06.008_bb0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.intimp.2016.06.008_bb0015","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2016.06.008_bb0020","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1089\/dna.2014.2760","article-title":"Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-kappaB pathway","volume":"34","author":"Feng","year":"2015","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI74942","article-title":"PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis","volume":"125","author":"Bueno","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2016.06.008_bb0030","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/hep.25938","article-title":"Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent","volume":"56","author":"Aoyama","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2016.06.008_bb0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tem.2014.11.003","article-title":"Poly(ADP-ribose) polymerases as modulators of mitochondrial activity","volume":"26","author":"Bai","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2016.06.008_bb0040","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1681\/ASN.2007060648","article-title":"Poly(ADP-ribose) polymerase-1 enhances transcription of the profibrotic CCN2 gene","volume":"19","author":"Okada","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0045","first-page":"472","article-title":"Poly(ADP-ribose) polymerase-1 in high glucose-induced epithelial-mesenchymal transition during peritoneal fibrosis","volume":"29","author":"Lei","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.intimp.2016.06.008_bb0050","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jcph.96","article-title":"Radix puerariae: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use","volume":"53","author":"Zhang","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0055","first-page":"1815","article-title":"The effect of puerarin against IL-1beta-mediated leukostasis and apoptosis in retinal capillary endothelial cells (TR-iBRB2)","volume":"20","author":"Zhu","year":"2014","journal-title":"Mol. Vis."},{"key":"10.1016\/j.intimp.2016.06.008_bb0060","article-title":"Puerarin protects human neuroblastoma SH-SY5Y cells against glutamate-induced oxidative stress and mitochondrial dysfunction","author":"Zhu","year":"2015","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0065","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jnutbio.2011.05.015","article-title":"Puerarin prevents isoprenaline-induced myocardial fibrosis in mice by reduction of myocardial TGF-beta1 expression","volume":"23","author":"Chen","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.intimp.2016.06.008_bb0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.regpep.2013.03.005","article-title":"Effects of felodipine combined with puerarin on ACE2-Ang (1-7)-Mas axis in renovascular hypertensive rat","volume":"184","author":"Bai","year":"2013","journal-title":"Regul. Pept."},{"key":"10.1016\/j.intimp.2016.06.008_bb0075","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1749-8546-5-36","article-title":"Preventive effects of Flos Perariae (Gehua) water extract and its active ingredient puerarin in rodent alcoholism models","volume":"5","author":"Zhang","year":"2010","journal-title":"Chin. Med."},{"key":"10.1016\/j.intimp.2016.06.008_bb0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.fct.2012.10.059","article-title":"Puerarin mediates hepatoprotection against CCl4-induced hepatic fibrosis rats through attenuation of inflammation response and amelioration of metabolic function","volume":"52","author":"Li","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0085","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/hep.22813","article-title":"Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride","volume":"49","author":"Park","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2016.06.008_bb0090","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1038\/srep06494","article-title":"Cell-based therapy for acute and chronic liver failures: distinct diseases, different choices","volume":"4","author":"Sun","year":"2014","journal-title":"Sci. Report."},{"key":"10.1016\/j.intimp.2016.06.008_bb0095","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.intimp.2014.11.014","article-title":"Baicalein pretreatment protects against liver ischemia\/reperfusion injury via inhibition of NF-kappaB pathway in mice","volume":"24","author":"Liu","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cmet.2011.03.004","article-title":"PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation","volume":"13","author":"Bai","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2016.06.008_bb0105","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.freeradbiomed.2012.05.036","article-title":"Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: therapeutic potential of mitochondrially targeted antioxidants","volume":"53","author":"Mukhopadhyay","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2016.06.008_bb0110","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.intimp.2015.04.001","article-title":"Protective effect of platycodin D on liver injury in alloxan-induced diabetic mice via regulation of Treg\/Th17 balance","volume":"26","author":"Chen","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0006-2952(99)00296-8","article-title":"Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries","volume":"59","author":"Bowie","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0120","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.intimp.2016.04.039","article-title":"Tetrandrine regulates hepatic stellate cell activation via TAK1 and NF-kappaB signaling","volume":"36","author":"Li","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.114.011079","article-title":"NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt\/mTOR and NFkappaB signaling pathways","volume":"131","author":"Zhao","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2016.06.008_bb0130","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/hep.510270514","article-title":"Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor","volume":"27","author":"Hellerbrand","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2016.06.008_bb0135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(03)00178-8","article-title":"Gliotoxin-mediated apoptosis of activated human hepatic stellate cells","volume":"39","author":"Kweon","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0140","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.intimp.2015.02.023","article-title":"Leonurine ameliorates kidney fibrosis via suppressing TGF-beta and NF-kappaB signaling pathway in UUO mice","volume":"25","author":"Cheng","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0145","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2004.10.003","article-title":"Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis","volume":"128","author":"Oakley","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2016.06.008_bb0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/10408444.2015.1016216","article-title":"Characterization of the toxicological hazards of hydrocarbon solvents","volume":"45","author":"McKee","year":"2015","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0155","first-page":"817","article-title":"Bone marrow-derived cells play a major role in kidney fibrosis via proliferation and differentiation in the infiltrated site","volume":"2013","author":"Jang","year":"1832","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.intimp.2016.06.008_bb0160","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3109\/10715762.2012.686664","article-title":"Bone marrow derived cells and reactive oxygen species in hypertrophy of contralateral kidney of transient unilateral renal ischemia-induced mouse","volume":"46","author":"Jang","year":"2012","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.intimp.2016.06.008_bb0165","doi-asserted-by":"crossref","first-page":"21486","DOI":"10.3390\/ijms160921486","article-title":"The role of mitochondrial DNA in mediating alveolar epithelial cell apoptosis and pulmonary fibrosis","volume":"16","author":"Kim","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2016.06.008_bb0170","doi-asserted-by":"crossref","first-page":"L962","DOI":"10.1152\/ajplung.00073.2014","article-title":"Mitochondria in lung biology and pathology: more than just a powerhouse","volume":"306","author":"Schumacker","year":"2014","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0175","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrneph.2014.184","article-title":"Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease","volume":"10","author":"Kok","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0180","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-beta signaling and the fibrotic response","volume":"18","author":"Leask","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2016.06.008_bb0185","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jnutbio.2005.09.002","article-title":"Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin","volume":"17","author":"Zhang","year":"2006","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.intimp.2016.06.008_bb0190","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.fct.2013.02.051","article-title":"Anti-fibrotic effects of puerarin on CCl4-induced hepatic fibrosis in rats possibly through the regulation of PPAR-gamma expression and inhibition of PI3K\/Akt pathway","volume":"56","author":"Guo","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0195","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s11655-014-2010-4","article-title":"Kinematic effect of Chinese herbal fomentation on patients with chronic neck pain","volume":"20","author":"Liu","year":"2014","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.intimp.2016.06.008_bb0200","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.freeradbiomed.2012.04.030","article-title":"Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress","volume":"53","author":"Kim","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2016.06.008_bb0205","article-title":"Botanical drug puerarin attenuates 6-Hydroxydopamine (6-OHDA)-induced neurotoxicity via upregulating mitochondrial enzyme arginase-2","author":"Zhao","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0210","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.taap.2011.11.015","article-title":"Puerarin protects rat kidney from lead-induced apoptosis by modulating the PI3K\/Akt\/eNOS pathway","volume":"258","author":"Liu","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0215","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/hep.26763","article-title":"Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis","volume":"59","author":"Mukhopadhyay","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2016.06.008_bb0220","doi-asserted-by":"crossref","first-page":"e27123","DOI":"10.1371\/journal.pone.0027123","article-title":"Poly(ADP-ribose) polymerase 1 is indispensable for transforming growth factor-beta induced Smad3 activation in vascular smooth muscle cell","volume":"6","author":"Huang","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2016.06.008_bb0225","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1440-1746.2001.02378.x","article-title":"Enhanced polyadenosine diphosphate-ribosylation in cirrhotic liver and carcinoma tissues in patients with hepatocellular carcinoma","volume":"16","author":"Shiobara","year":"2001","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0230","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.ijcard.2012.06.050","article-title":"Inhibition of PARP prevents angiotensin II-induced aortic fibrosis in rats","volume":"167","author":"Wang","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0235","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.8343","article-title":"Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy","author":"Qin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2016.06.008_bb0240","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.yjmcc.2008.06.009","article-title":"PARP mediates structural alterations in diabetic cardiomyopathy","volume":"45","author":"Chiu","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0245","doi-asserted-by":"crossref","first-page":"e102148","DOI":"10.1371\/journal.pone.0102148","article-title":"PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1\/GSK-3beta and several PKC isoforms","volume":"9","author":"Deres","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2016.06.008_bb0250","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3892\/or.2013.2902","article-title":"Natural and glucosyl flavonoids inhibit poly(ADP-ribose) polymerase activity and induce synthetic lethality in BRCA mutant cells","volume":"31","author":"Maeda","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2016.06.008_bb0255","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2174\/092986712803414150","article-title":"Specific noncovalent interactions at protein-ligand interface: implications for rational drug design","volume":"19","author":"Zhou","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.intimp.2016.06.008_bb0260","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.2174\/0929867311320150005","article-title":"Computational peptidology: a new and promising approach to therapeutic peptide design","volume":"20","author":"Zhou","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.intimp.2016.06.008_bb0265","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.molimm.2014.09.009","article-title":"The role of poly(ADP-ribose) polymerase-1 inhibitor in carrageenan-induced lung inflammation in mice","volume":"63","author":"Ahmad","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2016.06.008_bb0270","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.freeradbiomed.2010.09.021","article-title":"Menadione triggers cell death through ROS-dependent mechanisms involving PARP activation without requiring apoptosis","volume":"49","author":"Loor","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2016.06.008_bb0275","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1523\/JNEUROSCI.2702-14.2015","article-title":"Mitochondrial ATP-Mg\/pi carrier SCaMC-3\/Slc25a23 counteracts PARP-1-dependent fall in mitochondrial ATP caused by excitotoxic insults in neurons","volume":"35","author":"Rueda","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2016.06.008_bb0280","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/cvr\/cvn264","article-title":"PARP-1 suppresses adiponectin expression through poly(ADP-ribosyl)ation of PPAR gamma in cardiac fibroblasts","volume":"81","author":"Huang","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.intimp.2016.06.008_bb0285","doi-asserted-by":"crossref","first-page":"e81928","DOI":"10.1371\/journal.pone.0081928","article-title":"PARP inhibition attenuates acute kidney allograft rejection by suppressing cell death pathways and activating PI-3K-Akt cascade","volume":"8","author":"Kalmar-Nagy","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2016.06.008_bb0290","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cmet.2012.06.016","article-title":"The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease","volume":"16","author":"Bai","year":"2012","journal-title":"Cell Metab."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916302430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916302430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T22:48:59Z","timestamp":1568069339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576916302430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":58,"alternative-id":["S1567576916302430"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2016.06.008","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Puerarin protects against CCl4-induced liver fibrosis in mice: possible role of PARP-1 inhibition","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2016.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}